在静脉形缺陷中依赖尺寸的纳米粒子积累
Kathleen Cullion1,2, Claire A Ostertag-Hill1,3, Weimin Tang1,2
1Laboratory for Biomaterials and Drug Delivery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
概括
较小的纳米粒子 (NP) 通过增强的透和保留 (EPR) 效应在静脉形 (VMs) 中呈现增强的积累. 这项研究确定了VM药物输送的最佳NP大小,提高了治疗疗效和降低毒性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 血管生物学 血管生物学
背景情况:
- 目前用于静脉形 (VMs) 的治疗包括具有毒性副作用的全身药物或具有高风险的复杂程序.
- 纳米颗粒 (NP) 提供了一种潜在的策略,可以改善向VMs的药物输送,通过增强透和保留 (EPR) 效应提高疗效并减少全身毒性.
- 在VM中NP大小对EPR的影响在很大程度上仍未被探索.
研究的目的:
- 通过增强透和保留 (EPR) 效应,研究纳米粒子大小对静脉形 (VMs) 内积累的影响.
- 确定在虚拟机中被动积累的最佳纳米粒子大小,为未来的治疗策略提供信息.
主要方法:
- 通过使用含有常见VM相关突变的特定内皮细胞建立了皮下VMs的小鼠模型.
- 多种尺寸 (20,50,80,180 nm) 的空心纳米粒子 (NP) 被涂上聚乙烯糖醇 (PEG) 并与光体结合,被系统地施用.
- 在VM和器官内NP积累量化使用共聚焦显微镜和体内成像系统.
主要成果:
- PEGylated空心二氧化NP表现出水力动力直径在31.6nm到232nm之间.
- 与较大的NP相比,较小的NP在虚拟机中显示出明显更大的积累.
- 具体来说,20纳米NP的积累比50纳米NP的积累大2倍,比80纳米以上NP的积累大6倍 (P < .01).
结论:
- 这项研究确定20纳米是通过EPR效应在静脉形中纳米粒子积累的最佳尺寸.
- 这些发现为开发尺寸优化纳米粒子用于向VM治疗提供了关键的基础.
- 优化NP大小可以提高治疗疗效,并最大限度地减少VM管理中的非目标毒性.
相关概念视频
Venous Thrombosis I: Introduction
721
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
721
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
444
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
444


